UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P.1.33: 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE SENSITIZES COLON CANCER (CC) CELLS TO TRAIL THROUGH MODULATION OF DEATH RECEPTOR (DR)5 AND SURVIVIN

Digestive and liver disease, 2011, Vol.43, p.S159-S159

2011

Volltextzugriff (PDF)

The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies

Current molecular medicine, 2011-02, Vol.11 (1), p.26-30

2011

Volltextzugriff (PDF)

P.11.1: Azathioprine in the Maintenance of Steroid-Free Remission in Inflammatory Bowel Disease Patients: Efficacy and Safety in Five Years of Follow-Up

Digestive and liver disease, 2017-03, Vol.49, p.e202-e202

2017

Volltextzugriff (PDF)

P.07.13 FOUR-YEAR EFFICACY AND SAFETY OF AZATHIOPRINE TREATMENT IN THE MAINTAINANCE OF STEROID-FREE REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS

Digestive and liver disease, 2016-02, Vol.48, p.e162-e162

2016

Volltextzugriff (PDF)

P.06.15 SAFETY OF ANTI-TNFA THERAPY IN IBD: AN ITALIAN EXPERIENCE

Digestive and liver disease, 2012-03, Vol.44, p.S124-S124

2012

Volltextzugriff (PDF)

P.06.14 ADHERENCE TO ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPIES IN INFLAMMATORY BOWEL DISEASES: EXPERIENCE FROM FOUR REFERRAL ITALIAN CENTERS

Digestive and liver disease, 2012-03, Vol.44, p.S123-S124

2012

Volltextzugriff (PDF)

OC.06.1: INHIBITION OF COLITIS BY IL-25 ASSOCIATES WITH INDUCTION OF ALTERNATIVELY ACTIVATED MACROPHAGES

Digestive and liver disease, 2011, Vol.43, p.S130-S130

2011

Volltextzugriff (PDF)

P.1.40: IL-21 PRODUCTION IS POSITIVELY REGULATED BY IL-15 IN CELIAC DISEASE MUCOSA

Digestive and liver disease, 2011, Vol.43, p.S161-S161

2011

Volltextzugriff (PDF)

OC.06.2: ROLE OF INTERLEUKIN-21 IN THE GROWTH OF COLITIS-ASSOCIATED COLON CANCER

Digestive and liver disease, 2011, Vol.43, p.S130-S131

2011

Volltextzugriff (PDF)

P.1.101: LACTOBACILLI CASEI (LC) REDUCE TRYPSIN EXPRESSION IN INTESTINAL CELLS THEREBY LEADING TO INACTIVATION OF PAR2 AND UP-REGULATION OF ZO-1

Digestive and liver disease, 2011, Vol.43, p.S181-S181

2011

Volltextzugriff (PDF)

P.103 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE, A NOVEL DERIVATIVE OF 5-AMINOSALICYLIC ACID, INDUCES DR4 AND DR5 AND ENHANCES TRAIL-INDUCED APOPTOSIS IN COLON CANCER (CC) CELLS

Digestive and liver disease, 2010, Vol.42, p.S139-S139

2010

Volltextzugriff (PDF)

MESALAZINE'S ANTI-INFLAMMATORY ACTION THROUGH THE PPARγ IN CELIAC DISEASE

Digestive and liver disease, 2009, Vol.41, p.S91-S92

2009

Volltextzugriff (PDF)

COLON MUCOSA CULTURE OF BIOPSIES FROM PATIENTS WITH UNTREATED COELIAC DISEASE, AN ALTERNATIVE DIAGNOSTIC SITE

Digestive and liver disease, 2009, Vol.41, p.S91-S91

2009

Volltextzugriff (PDF)

PA.43 MESALAZINE EFFECT ON CELIAC DISEASE MUCOSA

Digestive and liver disease, 2008, Vol.40, p.S91-S91

2008

Volltextzugriff (PDF)

OC3.09.1 THE ORAL MUCOSA PATCH TEST: A NEW TOOL TO IDENTIFY ALIMENTARY INTOLERANCE TO FOODS NICKEL CONTAINS

Digestive and liver disease, 2008, Vol.40, p.S62-S62

2008

Volltextzugriff (PDF)

PA.34 IMMUNO-CHROMATOGRAPHIC ASSAY (EU-TTG SCREEN) IN THE ORGAN CULTURE SYSTEM

Digestive and liver disease, 2008, Vol.40, p.S87-S88

2008

Volltextzugriff (PDF)

PA.38 ORGAN CULTURE SYSTEM AS A MACHINERY TO DETECT COELIAC DISEASE

Digestive and liver disease, 2008, Vol.40, p.S89-S89

2008

Volltextzugriff (PDF)

P605 Eight-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S505-S505

2020

Volltextzugriff (PDF)

OC3.05.1 CELIAC DISEASE DIAGNOSIS: HAS THE TIME COME TO CHANGE THE GOLD STANDARD?

Digestive and liver disease, 2008, Vol.40, p.S48-S49

2008

Volltextzugriff (PDF)

P.02.5 SIX-YEAR EFFICACY AND SAFETY OF AZATHIOPRINE TREATMENT IN THE MAINTENANCE OF STEROID-FREE REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS

Digestive and liver disease, 2018-03, Vol.50 (2), p.e134-e134

2018

Volltextzugriff (PDF)

P024 Stratification of ulcerative colitis patients according to distinctive tissue cytokine profiles

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S92-S92

2017

Volltextzugriff (PDF)

P543 Seven-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S385-S386

2019

Volltextzugriff (PDF)

P362 Six-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S287-S287

2018

Volltextzugriff (PDF)

Resources for assessing parents’ vaccine hesitancy: a systematic review of the literature

Journal of preventive medicine and hygiene, 2020-10, Vol.61 (3), p.E340-E373

2020

Volltextzugriff (PDF)

P530 Azathioprine in the maintenance of steroid-free remission in inflammatory bowel disease patients: efficacy and safety in five years of follow-up

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S349-S350

2017

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Englisch
(88)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Physics
(26)
Physical Sciences
(20)
Gastroenterology And Hepatology
(17)
Technology
(15)
Life Sciences & Biomedicine
(11)
Physics, Nuclear
(10)
Exact Sciences And Technology
(8)
Fysik
(7)
Instrumentation And Detectors
(7)
Natural Sciences
(7)
Naturvetenskap
(7)
Applied Sciences
(6)
Computer Science
(6)
Detectors
(6)
Engineering
(6)
Nuclear Experiment
(6)
Physics, Multidisciplinary
(6)
Engineering, Electrical & Electronic
(5)
Humans
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

P.1.33: 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE SENSITIZES COLON CANCER (CC) CELLS TO TRAIL THROUGH MODULATION OF DEATH RECEPTOR (DR)5 AND SURVIVIN

The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies

P.11.1: Azathioprine in the Maintenance of Steroid-Free Remission in Inflammatory Bowel Disease Patients: Efficacy and Safety in Five Years of Follow-Up

P.07.13 FOUR-YEAR EFFICACY AND SAFETY OF AZATHIOPRINE TREATMENT IN THE MAINTAINANCE OF STEROID-FREE REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS

P.06.15 SAFETY OF ANTI-TNFA THERAPY IN IBD: AN ITALIAN EXPERIENCE

P.06.14 ADHERENCE TO ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPIES IN INFLAMMATORY BOWEL DISEASES: EXPERIENCE FROM FOUR REFERRAL ITALIAN CENTERS

OC.06.1: INHIBITION OF COLITIS BY IL-25 ASSOCIATES WITH INDUCTION OF ALTERNATIVELY ACTIVATED MACROPHAGES

P.1.40: IL-21 PRODUCTION IS POSITIVELY REGULATED BY IL-15 IN CELIAC DISEASE MUCOSA

OC.06.2: ROLE OF INTERLEUKIN-21 IN THE GROWTH OF COLITIS-ASSOCIATED COLON CANCER

P.1.101: LACTOBACILLI CASEI (LC) REDUCE TRYPSIN EXPRESSION IN INTESTINAL CELLS THEREBY LEADING TO INACTIVATION OF PAR2 AND UP-REGULATION OF ZO-1

P.103 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE, A NOVEL DERIVATIVE OF 5-AMINOSALICYLIC ACID, INDUCES DR4 AND DR5 AND ENHANCES TRAIL-INDUCED APOPTOSIS IN COLON CANCER (CC) CELLS

MESALAZINE'S ANTI-INFLAMMATORY ACTION THROUGH THE PPARγ IN CELIAC DISEASE

COLON MUCOSA CULTURE OF BIOPSIES FROM PATIENTS WITH UNTREATED COELIAC DISEASE, AN ALTERNATIVE DIAGNOSTIC SITE

PA.43 MESALAZINE EFFECT ON CELIAC DISEASE MUCOSA

OC3.09.1 THE ORAL MUCOSA PATCH TEST: A NEW TOOL TO IDENTIFY ALIMENTARY INTOLERANCE TO FOODS NICKEL CONTAINS

PA.34 IMMUNO-CHROMATOGRAPHIC ASSAY (EU-TTG SCREEN) IN THE ORGAN CULTURE SYSTEM

PA.38 ORGAN CULTURE SYSTEM AS A MACHINERY TO DETECT COELIAC DISEASE

P605 Eight-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients

OC3.05.1 CELIAC DISEASE DIAGNOSIS: HAS THE TIME COME TO CHANGE THE GOLD STANDARD?

P.02.5 SIX-YEAR EFFICACY AND SAFETY OF AZATHIOPRINE TREATMENT IN THE MAINTENANCE OF STEROID-FREE REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS

P024 Stratification of ulcerative colitis patients according to distinctive tissue cytokine profiles

P543 Seven-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients

P362 Six-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients

Resources for assessing parents’ vaccine hesitancy: a systematic review of the literature

P530 Azathioprine in the maintenance of steroid-free remission in inflammatory bowel disease patients: efficacy and safety in five years of follow-up

Suchergebnisse filtern